Cell Biotech Co., Ltd. (KOSDAQ: A049960)
Health Care · Biotechnology · KR
₩14,960.00
-3.73% today · +17.7% 1Y
Cell Biotech Co., Ltd. (KOSDAQ: A049960) operates in the Biotechnology industry within the Health Care sector. The company is valued at $73.88M.
Over the last twelve months the share price has gained 17.7%, trading between 11.35K and 18.50K.
Tweenvest scores Cell Biotech Co., Ltd. across four factors: quality 71/100, value 54/100, dividend 89/100. Its strongest factor is dividend.
A049960 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $73.88M
- Revenue (TTM)
- $37.11M
- P/E
- 7.63
- EPS
- 1,959.70
- Dividend yield
- 4.01%
- Beta (5Y)
- 0.46
- 52-week high
- ₩18,500.00
- 52-week low
- ₩11,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.47 | +0.74% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.00 | +0.04% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.11 | +0.93% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $554.56 | +1.27% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $835.68 | +0.87% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $159.02 | +14.49% |
Figures last refreshed Aug 18, 2026.